Fatty acid compositions of red blood cell phospholipids in children with autism

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 74, Issue 4, 2006, Pages 215-221

  Bu, B ^a   Ashwood, P ^b   Harvey, D ^c   King, I B ^d   Water, J Van de ^a   Jin, L W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Medical Microbiology and Immunology   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDIC ACID; ERUCIC ACID; FATTY ACID; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID DERIVATIVE; SATURATED FATTY ACID;

ARTICLE; AUTISM; CELL MEMBRANE; CHILD; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; ERYTHROCYTE; FATTY ACID METABOLISM; FEMALE; HUMAN; HYPOTHESIS; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; ONSET AGE; PRIORITY JOURNAL;

AUTISTIC DISORDER; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; ERYTHROCYTES; FATTY ACIDS; HUMANS; INFANT; PHOSPHOLIPIDS;

EID: 33646491403     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2006.02.001     Document Type: Article

References (39)

1. Lord C., Pickles A., McLennan J., et al. Diagnosing autism: analyses of data from the Autism Diagnostic Interview. J. Autism Dev. Disord. 27 (1997) 501-517
2. Peet M., Laugharne J.D., Mellor J., and Ramchand C.N. Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients and the clinical effects of dietary supplementation. Prostaglandins Leukot. Essent. Fatty Acids 55 (1996) 71-75
3. Richardson A.J., Calvin C.M., Clisby C., et al. Fatty acid deficiency signs predict the severity of reading and related difficulties in dyslexic children. Prostaglandins Leukot. Essent. Fatty Acids 63 (2000) 69-74
4. Richardson A.J., Easton T., and Puri B.K. Red cell and plasma fatty acid changes accompanying symptom remission in a patient with schizophrenia treated with eicosapentaenoic acid. Eur. Neuropsychopharmacol. 10 (2000) 189-193
5. Richardson A.J., and Ross M.A. Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit/hyperactivity disorder dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot. Essent. Fatty Acids 63 (2000) 1-9
6. Arvindakshan M., Ghate M., Ranjekar P.K., Evans D.R., and Mahadik S.P. Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophrenia Res. 62 (2003) 195-204
7. Bell J.G., Sargent J.R., Tocher D.R., and Dick J.R. Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: a characteristic abnormality in neurodevelopmental disorders?. Prostaglandins Leukot. Essent. Fatty Acids 63 (2000) 21-25
8. Bell J.G., MacKinlay E.E., Dick J.R., MacDonald D.J., Boyle R.M., and Glen A.C. Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leukot. Essent. Fatty Acids 71 (2004) 201-204
9. Vancassel S., Durand G., Barthelemy C., et al. Plasma fatty acid levels in autistic children. Prostaglandins Leukot. Essent. Fatty Acids 65 (2001) 1-7
10. Ming X., Stein T.P., Brimacombe M., Johnson W.G., Lambert G.H., and Wagner G.C. Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot. Essent. Fatty Acids 73 (2005) 379-384
11. Chauhan A., Chauhan V., Brown W.T., and Cohen I. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferring-the antioxidant proteins. Life Sci. 75 (2004) 2539-2549
12. James S.J., Cutler P., Melnyk S., et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 80 (2004) 1611-1617
13. Croen L.A., Grether J.K., and Selvin S. Descriptive epidemiology of autism in a California population: who is at risk?. J. Autism Dev. Disord. 32 (2002) 217-224
14. Owley T., McMahon W., Cook E.H., et al. Multisite, double-blind, placebo-controlled trial of porcine secretin in autism,. J. Am. Acad. Child Adolesc. Psychiat. 40 (2001) 1293-1299
15. Lord C., Leventhal B.L., and Cook Jr. E.H. Quantifying the phenotype in autism spectrum disorders. Am. J. Med. Genet. 105 (2001) 36-38
16. Joseph R.M., Tager-Flusberg H., and Lord C. Cognitive profiles and social-communicative functioning in children with autism spectrum disorder. J. Child Psychol. Psychiat. 43 (2002) 807-821
17. DiLavore P.C., Lord C., and Rutter M. The pre-linguistic autism diagnostic observation schedule. J. Autism Dev. Disord. 25 (1995) 355-379
18. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR, Washington, DC, 1994.
19. World Health Organization, International Classification of Diseases (ICD-10), 1992.
20. Sparrow S.S., and Cicchetti D.V. The behavior inventory for rating development (BIRD): assessments of reliability and factorial validity. Appl. Res. Ment. Retard. 5 (1984) 219-231
21. Berument S.K., Rutter M., Lord C., Pickles A., and Bailey A. Autism screening questionnaire: diagnostic validity. Br. J. Psychiat. 175 (1999) 444-451
22. Mullen E.M. Mullen Scales of Early Learning: AGS Edition (1995), American Guidance Service, Inc.
23. World Medical Association, Declaration of Helsinki, Edinburgh, 2000.
24. Rose H.G., and Oklander M. Improved procedure for the extraction of lipids from human erythrocytes. J. Lipid Res. 6 (1965) 428-431
25. Siscovick D.S., Raghunathan T.E., King I.B., et al. Dietary intake and cell-membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274 (1995) 1363-1367
26. LePage G., and Roy C.C. Direct transesterification of all classes of lipids in a one-step reaction. J. Lipid Res. 27 (1986) 114-120
27. Lemaitre R.N., King I.B., Patterson R.E., Psaty B.M., Kestin M., and Heckbert S.R. Assessment of trans-fatty acid intake with a food frequency questionnaire and validation with adipose tissue levels of trans-fatty acids. Am. J. Epidemiol. 148 (1998) 1085-1093
28. Peet M., Shah S., Selvam K., and Ramchand C.N. Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients. World J. Biol. Psychiat. 5 (2004) 92-99
29. Ranjekar P.K., Hinge A., Hegde M.V., et al. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiat. Res. 121 (2003) 109-122
30. Stevens L.J., Zentall S.S., Deck J.L., et al. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am. J. Clin. Nutr. 62 (1995) 761-768
31. Arvindakshan M., Sitasawad S., Debsikdar V., et al. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biol. Psychiat. 53 (2003) 56-64
32. Valsta L.M., Salminen I., Aro A., and Mutanen M. Alpha-linolenic acid in rapeseed oil partly compensates for the effect of fish restriction on plasma long chain n-3 fatty acids. Eur. J. Clin. Nutr. 50 (1996) 229-235
33. Innis S.M., and Dyer R.A. Dietary canola oil alters hematological indices and blood lipids in neonatal piglets fed formula. J. Nutr. 129 (1999) 1261-1268
34. Kramer J.K., Sauer F.D., Farnworth E.R., Stevenson D., and Rock G.A. Hematological and lipid changes in newborn piglets fed milk-replacer diets containing erucic acid. Lipids 33 (1998) 1-10
35. Uauy R., and Castillo C. Lipid requirements of infants: implications for nutrient composition of fortified complementary foods. J. Nutr. 133 (2003) 2962S-2972S
36. Ursin V.M. Modification of plant lipids for human health: development of functional land-based omega-3 fatty acids. J. Nutr. 133 (2003) 4271-4274
37. Bretillon L., Chardigny J.M., Noel J.P., and Sebedio J.L. Desaturation and chain elongation of [1-14C]mono-trans isomers of linoleic and alpha-linolenic acids in perfused rat liver. J. Lipid Res. 39 (1998) 2228-2236
38. Clark-Taylor T., and Clark-Taylor B.E. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase. Med. Hypotheses 62 (2004) 970-975
39. Puri B.K., and Singh I. Normal phospholipid-related signal transduction in autism. Prog. Neuropsychopharmacol. Biol. Psychiat. 26 (2002) 1405-1407